Koyfin Home > Directory > Health Care > Amag Pharmaceuticals > Total Debt / Equity

Amag Pharmaceuticals Total Debt / Equity Chart (AMAG)

Amag Pharmaceuticals annual/quarterly Total Debt / Equity from 2014 to 2020. Debt to equity is a measure of leverage in a company and expressed as a ratio of the total debt relative to book value of equity.
  • Amag Pharmaceuticals Total Debt / Equity for the quarter ending June 06, 2020 was $123m a 52.75% increase of 65m year over year
  • Amag Pharmaceuticals Total Debt / Equity for the last 12 months ending June 06, 2020 was $123m a 52.75% increase of 65m year over year
  • Amag Pharmaceuticals Annual Total Debt / Equity for 2019 was $108m a 64.49% increase of 69m from 2018
  • Amag Pharmaceuticals Annual Total Debt / Equity for 2018 was $38m a -143.43% decrease of -55m from 2017
  • Amag Pharmaceuticals Annual Total Debt / Equity for 2017 was $93m a -13.56% decrease of -13m from 2016
Other Ratios Metrics:
  • Amag Pharmaceuticals Total Debt / Capital for the quarter ending September 09, 2018 was $27m a -79.63% decrease of -21m year over year
  • Amag Pharmaceuticals Other Liabilities for the quarter ending December 12, 2018 was $1m a -3,223.97% decrease of -46m year over year
View Chart On Koyfin

Quarterly AMAG Total Debt / Equity Data

06/2020$123m
03/2020$115m
12/2019$108m
09/2019$58m
06/2019$55m
03/2019$44m
12/2018$38m
09/2018$37m
06/2018$102m
03/2018$100m

Annual AMAG Total Debt / Equity Data

2019$108m
2018$38m
2017$93m
2016$106m
2015$106m
2014$108m